Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation

Xuan Jiang,Shuxiang Li,Hongbin Zhang,Liang-Liang Wang

DOI: https://doi.org/10.1016/j.compbiolchem.2020.107405

IF: 3.737

2021-02-01

Computational Biology and Chemistry

Abstract:<p>Opioids are well known for their potent analgesic efficacy and severe side effects. Studies have shown that analgesic effects are mediated by the downstream G-protein-dependent pathway of the μ-opioid receptor (MOR), and another β-arrestin-dependent pathway mediates side effects such as respiratory depression, constipation and tolerance <em>etc</em>. TRV130 is a biased ligand for G-protein-dependent pathway, which has high analgesia and has fewer side effects than morphine. In this study, the structure similarity search was performed on the IBSSC database using Oliceridine (TRV130) as a template. The 3D structure-based pharmacophore model was built and combined molecular docking prediction mode was selected to filter out small molecules, Finally, based on affinity prediction, four candidate molecules were obtained. Molecular dynamics simulations explored the detailed interaction mechanism of proteins with small molecules under dynamics. These results suggest that these candidate molecules are potential MOR agonists.</p>

biology,computer science, interdisciplinary applications

What problem does this paper attempt to address?

This paper attempts to discover potential biased agonists of μ - opioid receptor (MOR) through molecular docking, pharmacophore modeling and molecular dynamics simulation. Specifically, the main objectives of the study include:

1. **Virtual screening**: Based on the known biased agonists PZM21 and TRV130 as templates, conduct a structural similarity search for compounds in the IBSSC database to screen out compounds with potential biased agonist activity.

2. **Pharmacophore modeling**: Construct a pharmacophore model to further screen the compound library and ensure that the candidate compounds have pharmacodynamic characteristics similar to the known biased agonists.

3. **Molecular docking**: Use GOLD and SYBYL - X 2.0 software for molecular docking to evaluate the binding mode and affinity of the candidate compounds with MOR.

4. **Affinity prediction**: Use SeeSAR software to predict the binding affinity of the candidate compounds with MOR and exclude possible false - positive compounds through the PAINS filter.

5. **Molecular dynamics simulation**: Conduct molecular dynamics simulation on the complexes of the screened candidate compounds and MOR to evaluate their binding stability.

Finally, through the above methods, the researchers screened out four potential MOR - biased agonist candidate molecules from a large number of compounds. These molecules show good characteristics in terms of binding mode, affinity and stability, providing a new framework for further development of new MOR - biased agonists.